US · guidance
CMS Pub. 100-03, ch. 1, § 220.6.9
FDG PET for Refractory Seizures (Effective July 1, 2001)
Beginning July 1, 2001, Medicare covers FDG PET for pre-surgical evaluation for the purpose of
localization of a focus of refractory seizure activity.
Limitations: Covered only for pre-surgical evaluation.
Documentation that these conditions are met should be maintained by the referring physician in the
beneficiary's medical record, as is normal business practice.
(This NCD last reviewed June 2001.)
History
(Rev. 120; Issued: 05-06-10; Effective Date: 04-03-09; Implementation Date: 10-30-09)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
25e0563df4031ac7fb10905c6151d8d2d714da08a0800596ea960feb30fdd332
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.